{"data":[{"accessionNo":"0001274173-26-000152","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001070081","issuerName":"PTC THERAPEUTICS, INC.","ticker":"PTCT","cusip":"69366J200","securityClass":"Common Stock","eventDate":"2026-03-31","reportingPerson":"JANUS HENDERSON GROUP PLC","reportingCik":null,"personType":"HC","sharesOwned":7193433,"percentOfClass":8.7,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/ptct"},{"accessionNo":"0000947263-26-000046","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001070081","issuerName":"PTC THERAPEUTICS, INC.","ticker":"PTCT","cusip":"69366J200","securityClass":"Common Stock, $0.001 par value per share","eventDate":"2026-03-31","reportingPerson":"The Toronto-Dominion Bank","reportingCik":null,"personType":"FI","sharesOwned":3025945,"percentOfClass":3.7,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/ptct"},{"accessionNo":"0002100119-26-000940","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001070081","issuerName":"PTC Therapeutics Inc","ticker":"PTCT","cusip":"69366J200","securityClass":"Common Stock","eventDate":"2026-03-31","reportingPerson":"Vanguard Capital Management","reportingCik":null,"personType":"IA","sharesOwned":4284448,"percentOfClass":5.17,"filedAt":"2026-04-30","canonicalUrl":"https://xoomar.com/markets/stocks/ptct"},{"accessionNo":"0002100121-26-000623","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001070081","issuerName":"PTC Therapeutics Inc","ticker":"PTCT","cusip":"69366J200","securityClass":"Common Stock","eventDate":"2026-03-31","reportingPerson":"Vanguard Portfolio Management","reportingCik":null,"personType":"IA","sharesOwned":4871329,"percentOfClass":5.88,"filedAt":"2026-04-29","canonicalUrl":"https://xoomar.com/markets/stocks/ptct"},{"accessionNo":"0000102909-26-002132","formType":"SCHEDULE 13G/A","amendmentNo":11,"issuerCik":"0001070081","issuerName":"PTC Therapeutics Inc","ticker":"PTCT","cusip":"69366J200","securityClass":"Common Stock","eventDate":"2026-03-13","reportingPerson":"The Vanguard Group","reportingCik":null,"personType":"IA","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-03-27","canonicalUrl":"https://xoomar.com/markets/stocks/ptct"},{"accessionNo":"0001274173-26-000072","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001070081","issuerName":"PTC THERAPEUTICS, INC.","ticker":"PTCT","cusip":null,"securityClass":"Common Stock","eventDate":"2025-12-31","reportingPerson":"JANUS HENDERSON GROUP PLC","reportingCik":null,"personType":"HC","sharesOwned":4851332,"percentOfClass":6,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/ptct"},{"accessionNo":"0000947263-26-000005","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001070081","issuerName":"PTC THERAPEUTICS, INC.","ticker":"PTCT","cusip":null,"securityClass":"Common Stock, $0.001 par value per share","eventDate":"2025-12-31","reportingPerson":"The Toronto-Dominion Bank","reportingCik":null,"personType":"FI","sharesOwned":4138215,"percentOfClass":5.2,"filedAt":"2026-02-13","canonicalUrl":"https://xoomar.com/markets/stocks/ptct"},{"accessionNo":"0000902219-26-000080","formType":"SCHEDULE 13G/A","amendmentNo":7,"issuerCik":"0001070081","issuerName":"PTC Therapeutics, Inc.","ticker":"PTCT","cusip":null,"securityClass":"Common Stock","eventDate":"2025-12-31","reportingPerson":"Wellington Management Group LLP","reportingCik":null,"personType":"HC","sharesOwned":3867380,"percentOfClass":4.8,"filedAt":"2026-02-10","canonicalUrl":"https://xoomar.com/markets/stocks/ptct"},{"accessionNo":"0000902219-26-000080","formType":"SCHEDULE 13G/A","amendmentNo":7,"issuerCik":"0001070081","issuerName":"PTC Therapeutics, Inc.","ticker":"PTCT","cusip":null,"securityClass":"Common Stock","eventDate":"2025-12-31","reportingPerson":"Wellington Group Holdings LLP","reportingCik":null,"personType":"HC","sharesOwned":3867380,"percentOfClass":4.8,"filedAt":"2026-02-10","canonicalUrl":"https://xoomar.com/markets/stocks/ptct"},{"accessionNo":"0000902219-26-000080","formType":"SCHEDULE 13G/A","amendmentNo":7,"issuerCik":"0001070081","issuerName":"PTC Therapeutics, Inc.","ticker":"PTCT","cusip":null,"securityClass":"Common Stock","eventDate":"2025-12-31","reportingPerson":"Wellington Investment Advisors Holdings LLP","reportingCik":null,"personType":"HC","sharesOwned":3867380,"percentOfClass":4.8,"filedAt":"2026-02-10","canonicalUrl":"https://xoomar.com/markets/stocks/ptct"},{"accessionNo":"0000093751-26-000079","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001070081","issuerName":"PTC THERAPEUTICS INC","ticker":"PTCT","cusip":null,"securityClass":"COMMON STOCK","eventDate":"2025-12-31","reportingPerson":"STATE STREET CORPORATION","reportingCik":null,"personType":"HC","sharesOwned":4206126,"percentOfClass":5.2,"filedAt":"2026-02-09","canonicalUrl":"https://xoomar.com/markets/stocks/ptct"},{"accessionNo":"0002012383-25-002989","formType":"SCHEDULE 13G/A","amendmentNo":12,"issuerCik":"0001070081","issuerName":"PTC THERAPEUTICS, INC.","ticker":"PTCT","cusip":null,"securityClass":"Common Stock","eventDate":"2025-11-30","reportingPerson":"BlackRock, Inc.","reportingCik":null,"personType":"HC","sharesOwned":11904696,"percentOfClass":14.8,"filedAt":"2025-12-04","canonicalUrl":"https://xoomar.com/markets/stocks/ptct"},{"accessionNo":"0001172661-25-005148","formType":"SCHEDULE 13G/A","amendmentNo":5,"issuerCik":"0001070081","issuerName":"PTC THERAPEUTICS, INC.","ticker":"PTCT","cusip":null,"securityClass":"Common Stock, $0.001 par value per share","eventDate":"2025-09-30","reportingPerson":"Armistice Capital, LLC","reportingCik":null,"personType":"IA,OO","sharesOwned":3277272,"percentOfClass":4.08,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/ptct"},{"accessionNo":"0001172661-25-005148","formType":"SCHEDULE 13G/A","amendmentNo":5,"issuerCik":"0001070081","issuerName":"PTC THERAPEUTICS, INC.","ticker":"PTCT","cusip":null,"securityClass":"Common Stock, $0.001 par value per share","eventDate":"2025-09-30","reportingPerson":"Steven Boyd","reportingCik":null,"personType":"HC,IN","sharesOwned":3277272,"percentOfClass":4.08,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/ptct"},{"accessionNo":"0000102909-25-000196","formType":"SCHEDULE 13G/A","amendmentNo":10,"issuerCik":"0001070081","issuerName":"PTC Therapeutics Inc","ticker":"PTCT","cusip":null,"securityClass":"Common Stock","eventDate":"2025-09-30","reportingPerson":"The Vanguard Group","reportingCik":null,"personType":"IA","sharesOwned":8288999,"percentOfClass":10.43,"filedAt":"2025-10-30","canonicalUrl":"https://xoomar.com/markets/stocks/ptct"}],"updatedAt":"2026-10-29T08:39:26.960Z","source":"xoomar.com","docs":"https://xoomar.com/markets/api","license":"https://xoomar.com/terms","attribution":"Credit XOOMAR with a link to the dataset page on xoomar.com when you republish this data","canonicalUrl":"https://xoomar.com/markets/stocks/ptct","meta":{"source":"SEC","sourceAttribution":"Schedule 13D and 13G data: SEC.","notice":"10 requests a minute without a key, 30 with a free key. Get a free key at https://xoomar.com/signup?utm_source=api, register your app at https://xoomar.com/developers/register?utm_source=api, and credit the data as \"Data: XOOMAR\" together with the sourceAttribution line."}}